Medical Journals

The Dna Binding Domain of a Papillomavirus E2 Protein Programs a Chimeric Nuclease to Cleave Integrated Human Papillomavirus Dna in Hela Cervical Carcinoma Cells.

Authors:
  • Horner Stacy M
  • DiMaio Daniel

From: Yale University School of Medicine, Department of Genetics, 333 Cedar Street, SHM-141, New Haven, CT 06510, USA.

Journal of virology

  • Publish Date: Jun 2007
  • ISSN: 0022-538X
  • Volume: 81
  • Issue: 12
  • Pages: 6254-64
  • Medium: Print
  • Language: English
  • Citation (JAMA): Horner Stacy M, DiMaio Daniel, et al. The Dna Binding Domain of a Papillomavirus E2 Protein Programs a Chimeric Nuclease to Cleave Integrated Human Papillomavirus Dna in Hela Cervical Carcinoma Cells.. J. Virol. Jun 2007;81:6254-64

Abstract

Viral DNA binding proteins that direct nucleases or other protein domains to viral DNA in lytically or latently infected cells may provide a novel approach to modulate viral gene expression or replication. Cervical carcinogenesis is initiated by high-risk human papillomavirus (HPV) infection, and viral DNA persists in the cancer cells. To test whether a DNA binding domain of a papillomavirus protein can direct a nuclease domain to cleave HPV DNA in cervical cancer cells, we fused the DNA binding domain of the bovine papillomavirus type 1 (BPV1) E2 protein to the catalytic domain of the FokI restriction endonuclease, generating a BPV1 E2-FokI chimeric nuclease (BEF). BEF introduced DNA double-strand breaks on both sides of an E2 binding site in vitro, whereas DNA binding or catalytic mutants of BEF did not. After expression of BEF in HeLa cervical carcinoma cells, we detected cleavage at E2 binding sites in the integrated HPV18 DNA in these cells and also at an E2 binding site in cellular DNA. BEF-expressing cells underwent senescence, which required the DNA binding activity of BEF, but not its nuclease activity. These results demonstrate that DNA binding domains of viral proteins can target effector molecules to cognate binding sites in virally infected cells.

Mesh Headings (Keywords): Base Sequence, Binding Sites, Bovine papillomavirus 1, Catalytic Domain, DNA, DNA Damage, DNA-Binding Proteins, Deoxyribonucleases, Deoxyribonucleases, Type II Site-Specific, Hela Cells, Humans, Molecular Sequence Data, Mutation, Protein Binding, Protein Structure, Tertiary, Viral Proteins


Check for Full Text / PubMed Unique Identifier (PMID): 17392356


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.